What We'll Be Watching at ASCO | Fight Colorectal Cancer

ASCO?s almost here!

The annual meeting of the American Society of Clinical Oncology begins on June 3 in Chicago.? Fight Colorectal Cancer staff will be there, both in the Exhibit Hall with information about our work and attending scientific sessions to learn about the latest advances in colorectal cancer prevention and treatment.

ASCO Abstracts are available online for browsing.? We?ve been looking through them, hunting for the ones we think are important to find out more about at the meeting.? Here?s what we?re watching:

• The team at NSABP will be reporting on whether or not oxaliplatin adds to to benefits from 5-FU chemotherapy in stage II colon cancer.
• Both NSABP and a German group are presenting results as to whether adding oxaliplatin to chemotherapy used with radiation before surgery for rectal cancer increases response to treatment.
• Other rectal cancer studies will be looking at whether Xeloda? (capecitabine) can safely and effectively be substituted for 5-FU during pre-surgical chemoradiation.
• What?s the effect of an EGFR inhibitor (Erbitux? or Vectibix) on first-line treatment of advanced colorectal cancer?? Does KRAS status make a difference?? Two studies will report answers.

Besides major work which will be presented during the? oral abstract session session on Saturday, there are over 130 posters covering a variety of cutting-edge colorectal cancer research.? In addition, dozens of other posters look at colorectal cancer screening and prevention and supportive care for patients living with cancer.

• Do visit us in at the Patient Advocacy Booth if you are in Chicago for ASCO
• And watch this blog for details as they emerge during ASCO.
• Also follow us on Twitter: @fightcrc

?

?

Source: http://fightcolorectalcancer.org/research_news/2011/05/what_well_be_watching_at_asco

planet hollywood las vegas better homes and gardens george clooney site mole youtube music wow